On this episode of MesoTV, our Patients Services Director, Julie White, RN, BSN, OCN, sits down with our new Executive Director, Brian Lepacek, MDiv, CAE, to discuss his role and how he got to the foundation. If you haven’t met Brian yet, definitely check out this episode to get to know him.
Vivace Therapeutics Receives FDA Orphan Drug Designation for VT3989 for Mesothelioma Treatment
Vivace Therapeutics, a company that develops cancer treatments, announced on July 30, 2025, that the U.S. Food and Drug Administration (FDA) has granted its experimental
